These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 11908947
1. Characterization of the dominant autoreactive T-cell epitope in spontaneous autoimmune haemolytic anaemia of the NZB mouse. Shen CR, Ward FJ, Devine A, Luross JA, Lowrey PA, Wraith DC, Elson CJ, Barker RN. J Autoimmun; 2002 Mar; 18(2):149-57. PubMed ID: 11908947 [Abstract] [Full Text] [Related]
4. A 17-Mer self-peptide of acetylcholine receptor binds to B cell MHC class II, activates helper T cells, and stimulates autoantibody production and electrophysiologic signs of myasthenia gravis. Yoshikawa H, Lambert EH, Walser-Kuntz DR, Yasukawa Y, McCormick DJ, Lennon VA. J Immunol; 1997 Aug 01; 159(3):1570-7. PubMed ID: 9233656 [Abstract] [Full Text] [Related]
6. A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism. Wall KA, Hu JY, Currier P, Southwood S, Sette A, Infante AJ. J Immunol; 1994 May 01; 152(9):4526-36. PubMed ID: 8157967 [Abstract] [Full Text] [Related]
10. Pathogenic autoantibodies in the NZB mouse are specific for erythrocyte band 3 protein. Barker RN, de Sá Oliveira GG, Elson CJ, Lydyard PM. Eur J Immunol; 1993 Jul 01; 23(7):1723-6. PubMed ID: 8325343 [Abstract] [Full Text] [Related]
11. Rational optimization of tumor epitopes using in silico analysis-assisted substitution of TCR contact residues. Shang X, Wang L, Niu W, Meng G, Fu X, Ni B, Lin Z, Yang Z, Chen X, Wu Y. Eur J Immunol; 2009 Aug 01; 39(8):2248-58. PubMed ID: 19593772 [Abstract] [Full Text] [Related]
12. Peptides containing a dominant T-cell epitope from red cell band 3 have in vivo immunomodulatory properties in NZB mice with autoimmune hemolytic anemia. Shen CR, Youssef AR, Devine A, Bowie L, Hall AM, Wraith DC, Elson CJ, Barker RN. Blood; 2003 Nov 15; 102(10):3800-6. PubMed ID: 12829598 [Abstract] [Full Text] [Related]
13. Identification of MHC class II and TCR binding residues in the type II collagen immunodominant determinant mediating collagen-induced arthritis. Rosloniec EF, Whittington KB, Brand DD, Myers LK, Stuart JM. Cell Immunol; 1996 Aug 25; 172(1):21-8. PubMed ID: 8806802 [Abstract] [Full Text] [Related]
14. Immunodominance: intermolecular competition between MHC class II molecules by covalently linked T cell epitopes. Wang Y, Smith JA, Gefter ML, Perkins DL. J Immunol; 1992 May 15; 148(10):3034-41. PubMed ID: 1578129 [Abstract] [Full Text] [Related]
15. T cell tolerance is influenced by concomitant T cell recognition of cross-reactive self-peptides. Tam RC, Fedoseyeva EV, Moskalenko M, Garovoy MR, Benichou G. J Immunol; 1996 May 15; 156(10):3765-71. PubMed ID: 8621912 [Abstract] [Full Text] [Related]
16. Possibilities and limitations in the rational design of modified peptides for T cell mediated immunotherapy. de Haan EC, Moret EE, Wagenaar-Hilbers JP, Liskamp RM, Wauben MH. Mol Immunol; 2005 Feb 15; 42(3):365-73. PubMed ID: 15589325 [Abstract] [Full Text] [Related]
18. OSP/claudin-11-induced EAE in mice is mediated by pathogenic T cells primarily governed by OSP192Y residue of major encephalitogenic region OSP179-207. Kaushansky N, Hemo R, Eisenstein M, Ben-Nun A. Eur J Immunol; 2007 Jul 15; 37(7):2018-31. PubMed ID: 17549734 [Abstract] [Full Text] [Related]
19. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides. de Haan EC, Wagenaar-Hilbers JP, Liskamp RM, Moret EE, Wauben MH. Mol Immunol; 2005 Feb 15; 42(3):355-64. PubMed ID: 15589324 [Abstract] [Full Text] [Related]